Clinical Trial Update: Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing romiplostim to treat chemotherapy-induced low platelet counts in patients with lymphoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Thrombocytopenia

Drugs mentioned

• Nplate (romiplostim)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lymphoma Patients, Thrombocytopenia | Phase 2 | Status: COMPLETED